- Home
- MRVL vs BDX Comparison
MRVL vs BDX Comparison
Compare MRVL & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVL
- BDX
- Stock Information
- Founded
- MRVL 1995
- BDX 1897
- Country
- MRVL United States
- BDX United States
- Employees
- MRVL N/A
- BDX N/A
- Industry
- MRVL Semiconductors
- BDX Medical/Dental Instruments
- Sector
- MRVL Technology
- BDX Health Care
- Exchange
- MRVL Nasdaq
- BDX Nasdaq
- Market Cap
- MRVL 54.6B
- BDX 49.0B
- IPO Year
- MRVL 2000
- BDX 1962
- Fundamental
- Price
- MRVL $92.34
- BDX $193.80
- Analyst Decision
- MRVL Buy
- BDX Buy
- Analyst Count
- MRVL 31
- BDX 9
- Target Price
- MRVL $93.71
- BDX $212.88
- AVG Volume (30 Days)
- MRVL 23.2M
- BDX 1.3M
- Earning Date
- MRVL 08-28-2025
- BDX 11-06-2025
- Dividend Yield
- MRVL 0.26%
- BDX 2.15%
- EPS Growth
- MRVL N/A
- BDX 12.91
- EPS
- MRVL N/A
- BDX 5.47
- Revenue
- MRVL $7,234,900,000.00
- BDX $21,386,000,000.00
- Revenue This Year
- MRVL $43.81
- BDX $9.41
- Revenue Next Year
- MRVL $19.59
- BDX $4.70
- P/E Ratio
- MRVL N/A
- BDX $35.45
- Revenue Growth
- MRVL 37.05
- BDX 7.86
- 52 Week Low
- MRVL $47.09
- BDX $163.33
- 52 Week High
- MRVL $127.48
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- MRVL 68.49
- BDX 56.83
- Support Level
- MRVL $86.03
- BDX $190.70
- Resistance Level
- MRVL $90.89
- BDX $195.33
- Average True Range (ATR)
- MRVL 3.24
- BDX 3.18
- MACD
- MRVL 1.12
- BDX 0.80
- Stochastic Oscillator
- MRVL 85.09
- BDX 82.17
About MRVL Marvell Technology Inc.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.